40 GENES FOUND
Show / hide columns
XML |
RDF |
TSV |
Page
of 1
KCNA1 Potassium channel, voltage gated shaker related subfamily A, member 1 Disease related genes FDA approved drug targets Predicted membrane proteins Voltage-gated ion channels Tissue enriched
KCNA10 Potassium channel, voltage gated shaker related subfamily A, member 10 FDA approved drug targets Predicted membrane proteins Voltage-gated ion channels Nucleoplasm Cytosol Tissue enhanced
KCNA2 Potassium channel, voltage gated shaker related subfamily A, member 2 Disease related genes FDA approved drug targets Predicted membrane proteins Transporters Voltage-gated ion channels Tissue enriched
KCNA3 Potassium channel, voltage gated shaker related subfamily A, member 3 FDA approved drug targets Predicted membrane proteins Transporters Voltage-gated ion channels Mixed
KCNA4 Potassium channel, voltage gated shaker related subfamily A, member 4 FDA approved drug targets Plasma proteins Predicted membrane proteins Voltage-gated ion channels Tissue enhanced
KCNA5 Potassium channel, voltage gated shaker related subfamily A, member 5 Disease related genes FDA approved drug targets Predicted membrane proteins Transporters Voltage-gated ion channels Tissue enhanced
KCNA6 Potassium voltage-gated channel subfamily A member 6 FDA approved drug targets Predicted membrane proteins Voltage-gated ion channels Not detected
KCNA7 Potassium channel, voltage gated shaker related subfamily A, member 7 FDA approved drug targets Predicted membrane proteins Voltage-gated ion channels Tissue enriched
KCNB1 Potassium channel, voltage gated Shab related subfamily B, member 1 Disease related genes FDA approved drug targets Predicted membrane proteins Transporters Voltage-gated ion channels Tissue enhanced
KCNB2 Potassium channel, voltage gated Shab related subfamily B, member 2 FDA approved drug targets Predicted membrane proteins Voltage-gated ion channels Nucleoli Plasma membrane Midbody Tissue enhanced
KCNC1 Potassium channel, voltage gated Shaw related subfamily C, member 1 Disease related genes FDA approved drug targets Predicted membrane proteins Voltage-gated ion channels Nucleus Nuclear membrane Vesicles Cytosol Tissue enriched
KCNC2 Potassium channel, voltage gated Shaw related subfamily C, member 2 FDA approved drug targets Predicted membrane proteins Voltage-gated ion channels Plasma membrane Cytosol Tissue enriched
KCNC3 Potassium channel, voltage gated Shaw related subfamily C, member 3 Disease related genes FDA approved drug targets Predicted intracellular proteins Predicted membrane proteins Transporters Voltage-gated ion channels Tissue enhanced
KCNC4 Potassium channel, voltage gated Shaw related subfamily C, member 4 Predicted membrane proteins Voltage-gated ion channels Nucleoli Cytosol Mixed
KCND1 Potassium channel, voltage gated Shal related subfamily D, member 1 FDA approved drug targets Predicted intracellular proteins Predicted membrane proteins Voltage-gated ion channels Nucleus Mixed
KCND2 Potassium channel, voltage gated Shal related subfamily D, member 2 Disease related genes FDA approved drug targets Predicted intracellular proteins Predicted membrane proteins Transporters Voltage-gated ion channels Tissue enhanced
KCND3 Potassium channel, voltage gated Shal related subfamily D, member 3 Disease related genes FDA approved drug targets Predicted membrane proteins Transporters Voltage-gated ion channels Mixed
KCNF1 Potassium channel, voltage gated modifier subfamily F, member 1 Plasma proteins Predicted membrane proteins Transporters Voltage-gated ion channels Golgi apparatus Tissue enriched
KCNG1 Potassium channel, voltage gated modifier subfamily G, member 1 Predicted intracellular proteins Predicted membrane proteins Voltage-gated ion channels Vesicles Tissue enhanced
KCNG2 Potassium channel, voltage gated modifier subfamily G, member 2 Predicted membrane proteins Voltage-gated ion channels Not detected
KCNG3 Potassium channel, voltage gated modifier subfamily G, member 3 Predicted membrane proteins Voltage-gated ion channels Cytoplasmic bodies Tissue enhanced
KCNG4 Potassium channel, voltage gated modifier subfamily G, member 4 Predicted membrane proteins Voltage-gated ion channels Not detected
KCNH1 Potassium channel, voltage gated eag related subfamily H, member 1 Disease related genes Potential drug targets Predicted membrane proteins Transporters Voltage-gated ion channels Vesicles Tissue enriched
KCNH2 Potassium channel, voltage gated eag related subfamily H, member 2 Disease related genes FDA approved drug targets Plasma proteins Predicted membrane proteins Transporters Voltage-gated ion channels Tissue enhanced
KCNH3 Potassium channel, voltage gated eag related subfamily H, member 3 Predicted membrane proteins Transporters Voltage-gated ion channels Nucleus Mitochondria Group enriched
KCNH4 Potassium channel, voltage gated eag related subfamily H, member 4 Predicted membrane proteins Voltage-gated ion channels Tissue enhanced
KCNH5 Potassium channel, voltage gated eag related subfamily H, member 5 Predicted membrane proteins Voltage-gated ion channels Microtubules Mitotic spindle Tissue enhanced
KCNH6 Potassium channel, voltage gated eag related subfamily H, member 6 Predicted membrane proteins Voltage-gated ion channels Tissue enhanced
KCNH7 Potassium channel, voltage gated eag related subfamily H, member 7 Predicted membrane proteins Voltage-gated ion channels Tissue enriched
KCNH8 Potassium channel, voltage gated eag related subfamily H, member 8 Predicted membrane proteins Voltage-gated ion channels Tissue enhanced
KCNQ1 Potassium channel, voltage gated KQT-like subfamily Q, member 1 Disease related genes FDA approved drug targets Plasma proteins Predicted membrane proteins Transporters Voltage-gated ion channels Tissue enhanced
KCNQ2 Potassium channel, voltage gated KQT-like subfamily Q, member 2 Disease related genes FDA approved drug targets Plasma proteins Predicted intracellular proteins Predicted membrane proteins Transporters Voltage-gated ion channels Endoplasmic reticulum Tissue enriched
KCNQ3 Potassium channel, voltage gated KQT-like subfamily Q, member 3 Disease related genes FDA approved drug targets Predicted membrane proteins Transporters Voltage-gated ion channels Tissue enriched
KCNQ4 Potassium channel, voltage gated KQT-like subfamily Q, member 4 Disease related genes Potential drug targets Predicted membrane proteins Transporters Voltage-gated ion channels Mixed
KCNQ5 Potassium channel, voltage gated KQT-like subfamily Q, member 5 Predicted intracellular proteins Predicted membrane proteins Voltage-gated ion channels Vesicles Tissue enhanced
KCNS1 Potassium voltage-gated channel, modifier subfamily S, member 1 Predicted membrane proteins Transporters Voltage-gated ion channels Tissue enhanced
KCNS2 Potassium voltage-gated channel, modifier subfamily S, member 2 Predicted membrane proteins Transporters Voltage-gated ion channels Tissue enhanced
KCNS3 Potassium voltage-gated channel, modifier subfamily S, member 3 Predicted intracellular proteins Predicted membrane proteins Transporters Voltage-gated ion channels Golgi apparatus Plasma membrane Cytosol Tissue enhanced
KCNV1 Potassium channel, voltage gated modifier subfamily V, member 1 Predicted membrane proteins Voltage-gated ion channels Tissue enriched
KCNV2 Potassium channel, voltage gated modifier subfamily V, member 2 Disease related genes Potential drug targets Predicted membrane proteins Voltage-gated ion channels Tissue enriched
Page
of 1